With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Nancy Birdsall, Senior Fellow, President Emeritus, Center for Global Development
Sebastian Bauhoff, Senior Fellow, Center for Global Development
Justin Sandefur, Senior Fellow, Center for Global Development
Numerous studies find that child health suffers when children are exposed to conflict, and armed conflicts are more likely to occur in poor countries with weak states. Nigeria is among the most conflict-prone countries in the world, experiencing the highest number of conflict-related deaths of all Sub-Saharan African countries in many of the years since 2000, with a peak in 2012. In this paper, researchers at the Urban Institute and the Center for Global Development are studying the relationship between child health and conflict in Nigeria by combining geo-coded data from the Demographic and Health Survey (DHS) of 2013 and the Social Conflict Analysis Database. In both urban and rural areas of Nigeria, they find significant increases in child wasting (acute malnutrition) in 2013 associated with proximity to violent conflict in 2012. In urban areas, infant mortality also increased significantly in 2003-2013, when the mother was exposed to conflict during pregnancy. They will discuss these findings and their implications, as well as some of the challenges to studying health in conflict-torn places.
With the goal of driving down drug costs, governments across the globe have instituted various forms of pharmaceutical price control policies. Understanding the impacts of such policies is particularly important in low- and middle-income countries, where lack of insurance coverage means that prices can serve as a barrier to access for patients and lack of effective quality control may allow for low-quality medicines in the market. In her paper, Emma Boswell Dean examines the theoretical effects of price controls in such markets and then measures the empirical effects of one implementation of pharmaceutical price controls, in which the Indian government placed price ceilings on a set of essential medicines.
This unique conference is designed to convene both the new industrial policy thinkers, who have studied the history of government intervention, and blended finance practitioners, who are involved in setting up the institutions and procedures that will use official development finance to subsidise private enterprise in developing countries. These two communities too often work in isolation and have much to learn from each other.
The conference will combine scholar presentations with high-level policy discussions. Please see the preliminary programme for a list of sessions and speakers, in addition to more details about the conference.
Please join us for this “first of its kind” conference and feel free to share this invitation with your network and encourage your colleagues to attend. We want to reach as many people who work in private sector development as possible.
In May 2017 the G20 Ministers of Finance appointed the Eminent Persons’ Group (EPG) on global financial governance, led by the Deputy Prime Minister of Singapore Tharman Shanmugaratnam, to review the governance of the international financial institutions, looking at their coherence and effectiveness in supporting the Agenda 2030 for Sustainable Development, managing capital flows, assessing risks to financial resilience and addressing non-financial threats to growth and stability.
The Center for Global Development (CGD) and The Global Financing Facility (GFF) invite you to the co-hosted Twitter Chat: Global Financing Facility: Investing in People. This interactive chat will discuss the details of GFF’s results-based model, its approach to sustainable global health financing, and scaling the impact of this innovative program over its planned expansion period (2018-2023).